Drugs / SC-007
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03253185 | Sep 2017 → Mar 2018 | colorectal cancer, gastric cancer | AbbVie | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SC-007 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03253185 ↗ |
| Route | Intravenous | “intravenous” NCT03253185 ↗ |